Special Considerations for Emerging Technologies Series

The SC CTSI Regulatory Science team, in collaboration with the USC + CHLA Alpha Clinic, has launched a new self-paced training module, Cell and Gene Therapy Trials, as part of a new series, Special Considerations for Emerging Technologies. Drawing on resources from the FDA, the National Institutes of Health, clinical research organizations, and the expertise of key stakeholders within the USC + CHLA Alpha Clinic, the series is designed to train academic researchers in the quality management of emerging technologies, such as regenerative medicine, throughout the clinical trial lifecycle. The module may be completed as a standalone course or as a supplement to the Clinical Trial Quality Training Series.

This course focuses on implementing quality practices for clinical trials involving cell and gene therapies (CGTs). It includes four chapters that introduce fundamental concepts in CGTs, examine opportunities and challenges inherent in CGT clinical trials, and provide practical case studies along with actionable resources such as templates and checklists.

Earn a Certificate of Completion and Digital Badge for completing each course. What is a badge? 

Go to the SC CTSI Learning Network catalog listing for the Cell and Gene Therapy Trials module and enroll for free!